Table 1.

Summary of mutations in 180 lung adenocarcinomas.

Mutation	N (%)
KRAS  G12A  G12C  G12D  G12F  G12R  G12V  G13C  G13D  Q61H	63 (35%)  7  24  15  2  1  10  1  1  2
EGFR  L858R  Exon 19 Δ  S768V	35 (19%)  21  13  1
No EGFR or KRAS mutations	82 (46%)